Skip to content
10-Q

Quarterly Report

SHENGTAI PHARMACEUTICAL, INC.

0001144204-11-063974

← back to feed
Filed
Nov 14, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Nov 7, 2011 9.58M sh
Short Term Debt Q1 2012 · Sep 30, 2011 $63.48M
Short Term Debt Q1 2012 · Jun 30, 2011 $48.09M
Stockholders Equity Q1 2012 · Sep 30, 2011 $60.99M
Stockholders Equity Q1 2012 · Jun 30, 2011 $59.62M
Current Liabilities Q1 2012 · Sep 30, 2011 $91.98M
Current Liabilities Q1 2012 · Jun 30, 2011 $84.62M
Current Assets Q1 2012 · Sep 30, 2011 $55.41M
Current Assets Q1 2012 · Jun 30, 2011 $48.09M
Total Assets Q1 2012 · Sep 30, 2011 $152.96M
Total Assets Q1 2012 · Jun 30, 2011 $144.24M
Capex Q1 2012 · Sep 30, 2010 $2.09M
Operating Cash Flow Q1 2012 · Sep 30, 2010 $4.47M
Cash And Equivalents Q1 2012 · Sep 30, 2010 $3.8M
Cash And Equivalents Q1 2012 · Jun 30, 2010 $4.12M
Sga Expense Q1 2012 · Sep 30, 2010 $2.58M
Net Income Q1 2012 · Sep 30, 2010 $1.64M
Operating Income Q1 2012 · Sep 30, 2010 $3.44M
Gross Profit Q1 2012 · Sep 30, 2010 $6.02M
Cost Of Revenue Q1 2012 · Sep 30, 2010 $28.63M
Revenue Q1 2012 · Sep 30, 2010 $34.64M